RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Acute Lung Injury
Accession: DOID:9004610
browse the term
Definition: A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological).
Synonyms: exact_synonym: Acute Lung Injuries
primary_id: MESH:D055371 ; RDO:0007706
xref: EFO:0004610
G
Ace
angiotensin I converting enzyme
treatment
IEP
associated wit Escherichia coli Infections
RGD
PMID:29990483
RGD:40400897
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
severity treatment
IMP ISO IEP
human protein in a mouse model associated with avian influenza;protein:decreased expression:lung (mouse) associated with Escherichia coli Infections CTD Direct Evidence: therapeutic
CTD RGD
PMID:27302421 PMID:16001071 PMID:16001071 PMID:25391767 PMID:29990483
RGD:32716389 , RGD:32716389 , RGD:40818412 , RGD:40400897
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Acvr1
activin A receptor, type 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21297076
NCBI chr 2:58,336,450...58,456,840
Ensembl chr 2:58,278,656...58,457,169
G
Adar
adenosine deaminase, RNA-specific
treatment
ISO
RGD
PMID:18520702
RGD:10755331
NCBI chr 3:89,622,321...89,660,756
Ensembl chr 3:89,622,329...89,660,753
G
Adipoq
adiponectin, C1Q and collagen domain containing
treatment
IMP IDA
associated with Sepsis
RGD
PMID:22156343 PMID:23522481
RGD:5686380 , RGD:8695940
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adra2a
adrenergic receptor, alpha 2a
ISO
RGD
PMID:21542970
RGD:6480481
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Aff4
AF4/FMR2 family, member 4
treatment
ISO
RGD
PMID:31466050
RGD:155631268
NCBI chr11:53,240,807...53,312,657
Ensembl chr11:53,241,660...53,312,657
G
Ager
advanced glycosylation end product-specific receptor
ISO
associated with Hyperoxia; protein:decreased expression:bronchoalveolar lavage fluid (rat)
RGD
PMID:23576805
RGD:7244254
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
G
Akap12
A kinase anchor protein 12
ISO
mRNA,protein:increased expression:lung
RGD
PMID:23912647
RGD:14348970
NCBI chr10:4,216,329...4,309,471
Ensembl chr10:4,216,380...4,309,470
G
Akt1
thymoma viral proto-oncogene 1
severity
IMP
RGD
PMID:23904165
RGD:38676478
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Alb
albumin
ISO
RGD
PMID:22592748
RGD:6483494
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Alox15
arachidonate 15-lipoxygenase
IMP
RGD
PMID:19752233
RGD:5509626
NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
G
Apoa1
apolipoprotein A-I
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20972769
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Aqp5
aquaporin 5
ISO
associated with Disseminated Intravascular Coagulation;mRNA,protein:decreased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr15:99,488,909...99,492,710
Ensembl chr15:99,488,663...99,492,710
G
Ascl1
achaete-scute family bHLH transcription factor 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:20554700
NCBI chr10:87,326,681...87,329,522
Ensembl chr10:87,326,681...87,329,522
G
Bax
BCL2-associated X protein
ISO
associated with Endotoxemia
RGD
PMID:20663300
RGD:10054109
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
ISO
associated with Endotoxemia
RGD
PMID:20663300
RGD:10054109
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
C3
complement component 3
treatment
ISO
RGD
PMID:22763771
RGD:11040808
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
G
Casp12
caspase 12
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032
G
Casp3
caspase 3
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:29755641
RGD:13782288
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp8
caspase 8
treatment
ISO
RGD
PMID:29755641
RGD:13782288
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15612528
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav1
caveolin 1, caveolae protein
treatment
ISO
RGD
PMID:24919947
RGD:10045573
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Ccl2
C-C motif chemokine ligand 2
ISO
mRNA, protein:increased expression:lung
RGD
PMID:21767135
RGD:6480432
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl4
C-C motif chemokine ligand 4
ISO IEP
protein:increased expression:respiratory system fluid/secretion mRNA, protein:increased expression:lung
RGD
PMID:10679105 PMID:21906407 PMID:21767135
RGD:68880 , RGD:5683874 , RGD:6480432
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
G
Ccr1
C-C motif chemokine receptor 1
IMP
associated with Pancreatitis
RGD
PMID:17312463
RGD:5688151
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
G
Cd36
CD36 molecule
IMP
associated with Malaria
RGD
PMID:18483551
RGD:6893505
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cxcl1
C-X-C motif chemokine ligand 1
IEP
associated with Sepsis;mRNA:increased expression:lung
RGD
PMID:10069420
RGD:5135253
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl15
C-X-C motif chemokine ligand 15
disease_progression
ISO
associated with sepsis;protein:increased expression:blood serum (human)
RGD
PMID:28506137
RGD:40925937
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl2
C-X-C motif chemokine ligand 2
IEP ISO
mRNA, protein:increased expression:lung associated with Sepsis;mRNA:increased expression:lung protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:27525872 PMID:15557650 PMID:10069420 PMID:19106808
RGD:5135247 , RGD:5135253 , RGD:5147925
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl5
C-X-C motif chemokine ligand 5
IEP ISO
mRNA, protein:increased expression:lung associated with Reperfusion Injury
RGD
PMID:15557650 PMID:7814607
RGD:5135247 , RGD:5135256
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
G
Cxcr2
C-X-C motif chemokine receptor 2
treatment
IMP
associated with Pancreatitis
RGD
PMID:17014919
RGD:7257703
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
IEP ISO
mRNA:increased expression:lung
RGD
PMID:18367723 PMID:16882535
RGD:5135235 , RGD:5147744
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
ISO
RGD
PMID:16882535
RGD:5147744
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cysltr1
cysteinyl leukotriene receptor 1
treatment
IMP
associated with Endotoxemia
RGD
PMID:27703200
RGD:40903067
NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285
G
Ddit3
DNA-damage inducible transcript 3
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Edn1
endothelin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16625121
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
G
Egfr
epidermal growth factor receptor
IMP
RGD
PMID:20935109
RGD:5131862
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Elane
elastase, neutrophil expressed
treatment
ISO
protein:increased expression:perfusate: associated with Shock, Hemorrhagic;
RGD
PMID:15257085 PMID:18283562 PMID:17203197
RGD:10450548 , RGD:10450585 , RGD:10450587
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
G
Ephx1
epoxide hydrolase 1, microsomal
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26840748
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Ephx2
epoxide hydrolase 2, cytoplasmic
ISO
RGD
PMID:22051199
RGD:5688354
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Ern1
endoplasmic reticulum to nucleus signalling 1
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
G
F2
coagulation factor II
ISO
RGD
PMID:22804886
RGD:7387313
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F3
coagulation factor III
ISO
protein:increased expression: respiratory system fluid/secretion
RGD
PMID:21964405
RGD:11341740
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fadd
Fas associated via death domain
treatment
ISO
associated with Shock, Hemorrhagic
RGD
PMID:24122010
RGD:11341811
NCBI chr 7:144,132,060...144,136,178
Ensembl chr 7:144,131,055...144,136,200
G
Fas
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11778176
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
G
Fasl
Fas ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11778176
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fcgr1
Fc receptor, IgG, high affinity I
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 3:96,190,225...96,201,285
Ensembl chr 3:96,190,225...96,201,285
G
Fcgr2b
Fc receptor, IgG, low affinity IIb
treatment
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:170,786,186...170,804,141
Ensembl chr 1:170,786,186...170,804,116
G
Fcgr3
Fc receptor, IgG, low affinity III
ISO
RGD
PMID:19106808
RGD:5147925
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
G
Fga
fibrinogen alpha chain
ISO
protein:increased expression:blood (rat)
RGD
PMID:22804886
RGD:7387313
NCBI chr 3:82,933,460...82,940,934
Ensembl chr 3:82,933,383...82,940,934
G
Flt1
FMS-like tyrosine kinase 1
ISO
associated with Endotoxemia
RGD
PMID:21528367
RGD:5684427
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
G
Foxa1
forkhead box A1
ISO
mRNA,protein:increased expression:lung
RGD
PMID:19649697
RGD:151665511
NCBI chr12:57,585,750...57,594,815
Ensembl chr12:57,587,414...57,593,702
G
Gja1
gap junction protein, alpha 1
treatment
ISO
RGD
PMID:23576849
RGD:8662452
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
ISO
protein:decreased expression:lung (rat)
RGD
PMID:25581610
RGD:13504847
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gsr
glutathione reductase
ISO
RGD
PMID:7896613
RGD:7257562
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gzmb
granzyme B
IEP
RGD
PMID:20018616
RGD:5135517
NCBI chr14:56,496,293...56,499,791
Ensembl chr14:56,496,295...56,499,717
G
Hmgb1
high mobility group box 1
treatment
ISO
associated with Endotoxemia associated with Burns associated with Crush Injuries
RGD
PMID:19766246 PMID:23874764 PMID:30465396
RGD:4892587 , RGD:10402098 , RGD:34901874
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
IMP
RGD
PMID:16922808
RGD:5508470
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmox1
heme oxygenase 1
treatment
ISO
associated with Reperfusion Injury
RGD
PMID:20850789 PMID:20360627
RGD:4145326 , RGD:4140418
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hnrnpc
heterogeneous nuclear ribonucleoprotein C
IEP
protein:altered localization:lung (mouse)
RGD
PMID:19029002
RGD:10054390
NCBI chr14:52,310,834...52,341,462
Ensembl chr14:52,310,834...52,341,485
G
Hspa5
heat shock protein 5
treatment
ISO
associated with Crush Injuries
RGD
PMID:30465396
RGD:34901874
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Icam1
intercellular adhesion molecule 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:17973899 PMID:27525872 PMID:20569121
RGD:8547719
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ido1
indoleamine 2,3-dioxygenase 1
treatment
IMP
RGD
PMID:25278421
RGD:39939031
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ifng
interferon gamma
ISO
RGD
PMID:21767135
RGD:6480432
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il10
interleukin 10
treatment no_association
ISO
associated with Reperfusion Injury;protein:increased expression:lung, plasma DNA:SNP:promoter:-1082G>A (rs1800896) (human) DNA:SNP:promoter:rs3021097 (human)
RGD
PMID:23902576 PMID:23801594 PMID:30412745 PMID:30412745
RGD:7364984 , RGD:7365008 , RGD:14975158 , RGD:14975158
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
ISO
mRNA:increased expression:lung
RGD
PMID:15461830
RGD:4145512
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il17a
interleukin 17A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:28600744
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il18
interleukin 18
treatment
ISO
associated with Myocardial Reperfusion Injury
RGD
PMID:24223666
RGD:8655952
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1b
interleukin 1 beta
ISO IEP
protein:increased expression:serum protein:increased expression:lung mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:20663306 PMID:20153312 PMID:8613550 PMID:21767135 PMID:22982561 More...
RGD:4142531 , RGD:4142807 , RGD:4143193 , RGD:6480432 , RGD:7204498
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rl1
interleukin 1 receptor-like 1
IMP ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:21352201 PMID:21352201
RGD:5144222
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il1rn
interleukin 1 receptor antagonist
ISO
mRNA:increased expression:lung
RGD
PMID:15970097 PMID:8613550
RGD:4143168 , RGD:4143193
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il2
interleukin 2
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:21767135
RGD:6480432
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il22
interleukin 22
IMP
RGD
PMID:20498020
RGD:4888524
NCBI chr10:118,040,456...118,045,952
Ensembl chr10:118,040,847...118,045,952
G
Il4
interleukin 4
treatment
ISO
RGD
PMID:24681349
RGD:10402798
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il4i1
interleukin 4 induced 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:36537648
NCBI chr 7:44,485,712...44,490,233
Ensembl chr 7:44,465,811...44,490,233
G
Il6
interleukin 6
ISO
protein:increased expression:bronchoalveolar lavage, blood, lung (rat) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:32062619 PMID:19995278
RGD:11062103
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Irak3
interleukin-1 receptor-associated kinase 3
IEP
mRNA, protein:increased expression:lung (mouse)
RGD
PMID:21577093
RGD:36049795
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
G
Itgam
integrin alpha M
treatment
ISO
associated with Hemorrhagic Shock
RGD
PMID:1347308 PMID:16096539
RGD:329901922 , RGD:329901935
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
G
Itgb2
integrin beta 2
ISO
RGD
PMID:1374449
RGD:6482199
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
G
Jak3
Janus kinase 3
IMP
RGD
PMID:22359619
RGD:11531100
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
G
Kdr
kinase insert domain protein receptor
ISO
associated with Endotoxemia;mRNA, protein:decreased expression:lung
RGD
PMID:21528367
RGD:5684427
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Ltb4r2
leukotriene B4 receptor 2
severity
IMP
associated with Endotoxemia
RGD
PMID:27703200
RGD:40903067
NCBI chr14:55,995,379...56,001,523
Ensembl chr14:55,998,885...56,002,595
G
Mfn1
mitofusin 1
ISO
mRNA, protein:altered expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 3:32,583,594...32,633,384
Ensembl chr 3:32,583,614...32,633,388
G
Mfn2
mitofusin 2
ISO
mRNA, protein:increased expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr 4:147,958,043...147,989,527
Ensembl chr 4:147,958,056...147,989,161
G
Mir155
microRNA 155
treatment
IMP IEP
associated with Sepsis associated with sepsis;miRNA:increased expression:lung
RGD
PMID:30220274 PMID:31949845 PMID:28125526 PMID:27371731 PMID:27371731
RGD:21066348 , RGD:21408593 , RGD:24922218 , RGD:11566124 , RGD:11566124
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir21a
microRNA 21a
ISO
RNA:increased expression:lung
RGD
PMID:30542412
RGD:41410885
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
G
Mir223
microRNA 223
severity treatment
IMP ISO
RGD
PMID:28931657 PMID:32226458
RGD:21408568 , RGD:26884341
NCBI chr X:95,286,423...95,286,532
Ensembl chr X:95,286,423...95,286,532
G
Mir330
microRNA 330
ISO
associated with Disseminated Intravascular Coagulation;RNA:increased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr 7:18,915,390...18,915,487
Ensembl chr 7:18,915,390...18,915,487
G
Mir483
microRNA 483
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32062619
NCBI chr 7:142,208,661...142,208,733
Ensembl chr 7:142,208,661...142,208,733
G
Mir96
microRNA 96
ISO
associated with Disseminated Intravascular Coagulation;RNA:increased expression:lung:
RGD
PMID:24806323
RGD:11553933
NCBI chr 6:30,169,445...30,169,550
Ensembl chr 6:30,169,445...30,169,550
G
Mir99b
microRNA 99b
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33109608
NCBI chr17:18,050,450...18,050,519
Ensembl chr17:18,050,450...18,050,519
G
Mmp2
matrix metallopeptidase 2
ISO
RGD
PMID:23040778
RGD:13207316
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp7
matrix metallopeptidase 7
ISO
associated with Sepsis
RGD
PMID:21567117
RGD:9685338
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
G
Mmp9
matrix metallopeptidase 9
ISO
RGD
PMID:23040778
RGD:13207316
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mpo
myeloperoxidase
IEP
associated with Kidney Reperfusion Injury; protein:increased activity:lung
RGD
PMID:22092133
RGD:6909173
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mt1
metallothionein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16166738
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt2
metallothionein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16166738
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
G
Mylk
myosin, light polypeptide kinase
ISO
associated with Sepsis CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19374788 PMID:16399953
RGD:1581052
NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790
G
Neat1
nuclear paraspeckle assembly transcript 1 (non-protein coding)
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:34687491
NCBI chr19:5,874,736...5,895,508
Ensembl chr19:5,874,736...5,895,898
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:24812154
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Ngf
nerve growth factor
IMP
RGD
PMID:17673270
RGD:5144065
NCBI chr 3:102,377,235...102,428,329
Ensembl chr 3:102,377,235...102,428,329
G
Nlrp3
NLR family, pyrin domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:33012731
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Nod2
nucleotide-binding oligomerization domain containing 2
treatment
ISO
associated with Sepsis
RGD
PMID:22575870
RGD:8547530
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
G
Nos2
nitric oxide synthase 2, inducible
ISO
RGD
PMID:16882535
RGD:5147744
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nppa
natriuretic peptide precursor type A
ISO
RGD
PMID:23422200
RGD:7247713
NCBI chr 4:148,085,179...148,086,531
Ensembl chr 4:148,085,179...148,086,536
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
treatment
ISO
RGD
PMID:24669282 PMID:28065220
RGD:11035223 , RGD:13442501
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Opa1
OPA1, mitochondrial dynamin like GTPase
ISO
mRNA, protein:altered expression:lung (rat)
RGD
PMID:25560372
RGD:12437080
NCBI chr16:29,398,099...29,481,924
Ensembl chr16:29,398,152...29,473,702
G
P2ry12
purinergic receptor P2Y, G-protein coupled 12
ISO
associated with Shock, Hemorrhagic
RGD
PMID:21841533
RGD:6480522
NCBI chr 3:59,123,692...59,170,408
Ensembl chr 3:59,123,693...59,170,292
G
Pak1
p21 (RAC1) activated kinase 1
ISO
DNA:hypermethylation
RGD
PMID:23546543
RGD:11533951
NCBI chr 7:97,437,748...97,561,588
Ensembl chr 7:97,437,748...97,561,588
G
Parp1
poly (ADP-ribose) polymerase family, member 1
IMP
associated with Pancreatitis, Experimental, Acute
RGD
PMID:16127429
RGD:11075069
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pawr
PRKC, apoptosis, WT1, regulator
ISO
mRNA,protein:increased expression:lung,blood vessel:
RGD
PMID:17136598
RGD:9835397
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pecam1
platelet/endothelial cell adhesion molecule 1
ISO
RGD
PMID:22592748
RGD:6483494
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pfkfb3
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
IEP
associated with Endotoxemia;mRNA, protein:increased expression:lung (mouse)
RGD
PMID:31167111
RGD:41410778
NCBI chr 2:11,476,241...11,558,882
Ensembl chr 2:11,476,244...11,558,888
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
IMP
associated with endotoxemia
RGD
PMID:22198681 PMID:11714830
RGD:6482677 , RGD:38599213
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Pla2g2a
phospholipase A2, group IIA (platelets, synovial fluid)
severity
ISO
RGD
PMID:19235614
RGD:6482722
NCBI chr 4:138,559,168...138,562,500
Ensembl chr 4:138,559,171...138,562,497
G
Plau
plasminogen activator, urokinase
treatment
ISO
associated with Endotoxemia
RGD
PMID:21473829 PMID:23324284
RGD:5147760 , RGD:7241552
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
G
Pparg
peroxisome proliferator activated receptor gamma
ISO
protein:decreased expression:lung (rat) CTD Direct Evidence: therapeutic
CTD RGD
PMID:21153920 PMID:16083301
RGD:8553030
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Prdm1
PR domain containing 1, with ZNF domain
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33109608
NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497
G
Prkaa1
protein kinase, AMP-activated, alpha 1 catalytic subunit
IMP
RGD
PMID:21595935
RGD:6484539
NCBI chr15:5,172,641...5,211,380
Ensembl chr15:5,173,343...5,211,380
G
Proc
protein C
treatment
ISO
associated with Pseudomonas Infections associated with Intestinal Reperfusion Injury
RGD
PMID:16553944 PMID:18367148
RGD:11100043 , RGD:11250405
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Procr
protein C receptor, endothelial
treatment
ISO
RGD
PMID:20095324
RGD:13515130
NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP ISO
protein:increased expression:lung
RGD
PMID:20926798 PMID:19567182
RGD:5135287 , RGD:5135496
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Scgb1a1
secretoglobin, family 1A, member 1
ISO IMP
protein:decreased expression:lung
RGD
PMID:18420837 PMID:16226776
RGD:5143982 , RGD:5144142
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
G
Serpinc1
serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1
treatment
ISO
associated with Endotoxemia
RGD
PMID:17940748
RGD:11035256
NCBI chr 1:160,806,153...160,830,113
Ensembl chr 1:160,806,155...160,833,433
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
treatment
ISO
associated with Sepsis associated with Shock, Hemorrhagic;mRNA:increased expression:lung (rat)
RGD
PMID:25934465 PMID:18182560 PMID:10745022
RGD:11075078 , RGD:11080962 , RGD:11080967
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
treatment
ISO
RGD
PMID:11685347
RGD:8661650
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Sftpa1
surfactant associated protein A1
ISO
mRNA, protein:increased expression:pneumocyte
RGD
PMID:8569184
RGD:4143451
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
G
Sftpb
surfactant associated protein B
treatment
ISO
RGD
PMID:22295533
RGD:151667443
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Sftpd
surfactant associated protein D
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30060251
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
G
Sirt2
sirtuin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:32063085
NCBI chr 7:28,466,192...28,488,086
Ensembl chr 7:28,466,160...28,488,086
G
Slpi
secretory leukocyte peptidase inhibitor
severity treatment
ISO
associated with Endotoxemia
RGD
PMID:10092827 PMID:25466948
RGD:9999422 , RGD:9999425
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Tac1
tachykinin 1
IMP
RGD
PMID:19797759
RGD:5147812
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tacr1
tachykinin receptor 1
IMP
mRNA:increased expression:lung
RGD
PMID:18523300
RGD:5147819
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
G
Tff1
trefoil factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19880587
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
G
Tff2
trefoil factor 2 (spasmolytic protein 1)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19880587
NCBI chr17:31,360,036...31,363,256
Ensembl chr17:31,360,023...31,363,256
G
Tgfb1
transforming growth factor, beta 1
treatment
ISO IMP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16100012 PMID:25278421
RGD:39939031
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Thbd
thrombomodulin
treatment
IDA ISO
associated with Endotoxemia
RGD
PMID:19342415 PMID:19536047 PMID:20095324
RGD:5131887 , RGD:5685372 , RGD:13515130
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Timp2
tissue inhibitor of metalloproteinase 2
severity
ISO
RGD
PMID:10092827
RGD:9999422
NCBI chr11:118,191,887...118,246,237
Ensembl chr11:118,191,887...118,246,566
G
Tlr4
toll-like receptor 4
ISO
RGD
PMID:19567182
RGD:5135496
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
G
Tnf
tumor necrosis factor
no_association treatment
ISO
mRNA, protein:increased expression:lung protein:increased expression:respiratory system fluid/secretion DNA:SNP:promoter:-308G>A (rs1800629) (human) DNA:SNP:promoter:rs1799964 (human) associated with Liver Reperfusion Injury CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:34390737 PMID:21767135 PMID:19106808 PMID:30412745 PMID:30412745 PMID:11129814 More...
RGD:6480432 , RGD:5147925 , RGD:14975158 , RGD:14975158 , RGD:14995473
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip6
tumor necrosis factor alpha induced protein 6
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26313688
NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
G
Trem1
triggering receptor expressed on myeloid cells 1
exacerbates ameliorates
ISO
RGD
PMID:26832696 PMID:26832696
RGD:127284840 , RGD:127284840
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Txn1
thioredoxin 1
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:16298680
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
G
Usp18
ubiquitin specific peptidase 18
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33930521
NCBI chr 6:121,222,865...121,247,876
Ensembl chr 6:121,222,865...121,247,876
G
Vegfa
vascular endothelial growth factor A
ISO
associated with Endotoxemia;mRNA, protein:altered expression:lung, plasma
RGD
PMID:21528367
RGD:5684427
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vip
vasoactive intestinal polypeptide
ISO
associated with Endotoxemia CTD Direct Evidence: therapeutic
CTD RGD
PMID:8643465 PMID:20441697
RGD:4145303
NCBI chr10:5,589,131...5,597,617
Ensembl chr10:5,589,218...5,597,617
G
Xdh
xanthine dehydrogenase
treatment
ISO
RGD
PMID:9655743
RGD:13209002
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Zc3h12a
zinc finger CCCH type containing 12A
severity
IMP
associated with toxic shock syndrome
RGD
PMID:23422584
RGD:39938961
NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all